These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

687 related items for PubMed ID: 10839530

  • 1. Roles of PPARs in health and disease.
    Kersten S, Desvergne B, Wahli W.
    Nature; 2000 May 25; 405(6785):421-4. PubMed ID: 10839530
    [Abstract] [Full Text] [Related]

  • 2. [A clinical perspective, a frontiers of PPAR function].
    Suzawa M, Kato S.
    Nihon Rinsho; 2001 Nov 25; 59(11):2269-77. PubMed ID: 11712418
    [Abstract] [Full Text] [Related]

  • 3. The role of PPAR alpha in obesity.
    Seedorf U, Assmann G.
    Nutr Metab Cardiovasc Dis; 2001 Jun 25; 11(3):189-94. PubMed ID: 11590995
    [Abstract] [Full Text] [Related]

  • 4. PPAR alpha, fibrates, lipid metabolism and inflammation.
    Duval C, Fruchart JC, Staels B.
    Arch Mal Coeur Vaiss; 2004 Jun 25; 97(6):665-72. PubMed ID: 15283041
    [Abstract] [Full Text] [Related]

  • 5. [Peroxisome proliferator-activated receptors and atherosclerosis].
    Jin N, Wang X.
    Sheng Li Ke Xue Jin Zhan; 2004 Jan 25; 35(1):13-8. PubMed ID: 15127591
    [Abstract] [Full Text] [Related]

  • 6. [Role of the peroxisome proliferator-activated receptors (PPARS) in the regulation of lipids and inflammation control].
    Bocher V, Chinetti G, Fruchart JC, Staels B.
    J Soc Biol; 2002 Jan 25; 196(1):47-52. PubMed ID: 12134632
    [Abstract] [Full Text] [Related]

  • 7. The mechanisms of action of PPARs.
    Berger J, Moller DE.
    Annu Rev Med; 2002 Jan 25; 53():409-35. PubMed ID: 11818483
    [Abstract] [Full Text] [Related]

  • 8. Peroxisome proliferator-activated receptors (PPARs) in the control of bone metabolism.
    Giaginis C, Tsantili-Kakoulidou A, Theocharis S.
    Fundam Clin Pharmacol; 2007 Jun 25; 21(3):231-44. PubMed ID: 17521292
    [Abstract] [Full Text] [Related]

  • 9. [Peroxisome proliferator activated receptors PPARs: their role in carbohydrate and lipid metabolism].
    Andrééva-Gatéva P.
    Ann Biol Clin (Paris); 2003 Jun 25; 61(3):295-303. PubMed ID: 12805006
    [Abstract] [Full Text] [Related]

  • 10. [Molecular nutrition, role of the PPAR system in lipidic metabolism and its importance in obesity and diabetes mellitus].
    Uauy R, Martínez JI, Rojas CV.
    Rev Med Chil; 2000 Apr 25; 128(4):437-46. PubMed ID: 10962863
    [Abstract] [Full Text] [Related]

  • 11. [Peroxisome proliferator-activated receptors (PPARs) in obesity and insulin resistance development].
    Alemán G, Torres N, Tovar AR.
    Rev Invest Clin; 2004 Apr 25; 56(3):351-67. PubMed ID: 15612519
    [Abstract] [Full Text] [Related]

  • 12. [New concepts on the mechanism of action of fibrates and therapeutic prospectives in atherosclerosis].
    Fruchart JC, Staels B, Duriez P.
    Bull Acad Natl Med; 2001 Apr 25; 185(1):63-74; discussion 74-5. PubMed ID: 11474570
    [Abstract] [Full Text] [Related]

  • 13. Physiological and therapeutic roles of peroxisome proliferator-activated receptors.
    Berger J, Wagner JA.
    Diabetes Technol Ther; 2002 Apr 25; 4(2):163-74. PubMed ID: 12079620
    [Abstract] [Full Text] [Related]

  • 14. Implications of peroxisome proliferator-activated receptors (PPARS) in development, cell life status and disease.
    Keller JM, Collet P, Bianchi A, Huin C, Bouillaud-Kremarik P, Becuwe P, Schohn H, Domenjoud L, Dauça M.
    Int J Dev Biol; 2000 Aug 25; 44(5):429-42. PubMed ID: 11032176
    [Abstract] [Full Text] [Related]

  • 15. Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells.
    Marx N, Duez H, Fruchart JC, Staels B.
    Circ Res; 2004 May 14; 94(9):1168-78. PubMed ID: 15142970
    [Abstract] [Full Text] [Related]

  • 16. [Peroxisome proliferator-activated receptors (PPAR) in pathophysiology of the circulatory system and prospective use of agonists of these receptors in therapy].
    Bełtowski J, Wójcicka G, Jamroz A.
    Postepy Hig Med Dosw; 2003 May 14; 57(2):199-217. PubMed ID: 12866356
    [Abstract] [Full Text] [Related]

  • 17. Down-regulation of STAT5b transcriptional activity by ligand-activated peroxisome proliferator-activated receptor (PPAR) alpha and PPARgamma.
    Shipley JM, Waxman DJ.
    Mol Pharmacol; 2003 Aug 14; 64(2):355-64. PubMed ID: 12869640
    [Abstract] [Full Text] [Related]

  • 18. Simultaneous, bidirectional inhibitory crosstalk between PPAR and STAT5b.
    Shipley JM, Waxman DJ.
    Toxicol Appl Pharmacol; 2004 Sep 15; 199(3):275-84. PubMed ID: 15364543
    [Abstract] [Full Text] [Related]

  • 19. PPARs and the complex journey to obesity.
    Evans RM, Barish GD, Wang YX.
    Nat Med; 2004 Apr 15; 10(4):355-61. PubMed ID: 15057233
    [Abstract] [Full Text] [Related]

  • 20. PPARs: therapeutic targets for metabolic disease.
    Berger JP, Akiyama TE, Meinke PT.
    Trends Pharmacol Sci; 2005 May 15; 26(5):244-51. PubMed ID: 15860371
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.